North American Multicenter Volumetric CT Study for Clinical Staging of Malignant Pleural Mesothelioma: Feasibility and Logistics of Setting Up a Quantitative.

Slides:



Advertisements
Similar presentations
Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications 
Advertisements

Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 
Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.
Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer
Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals Regarding the Clinical Staging of Small Cell Lung Cancer.
Radiotherapeutic Management of Non–Small Cell Lung Cancer in the Minimal Resource Setting  Danielle Rodin, MD, Surbhi Grover, MD, MPH, Melody J. Xu, MD,
National Cancer Database Report on Pneumonectomy Versus Lung-Sparing Surgery for Malignant Pleural Mesothelioma  Vivek Verma, MD, Christopher A. Ahern,
Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization 
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification.
FISH Analysis of Crizotinib Target Genes ROS1/ALK/MET in Malignant Mesothelioma  Sandra Salvi, PhD, Serena Varesano, PhD, Simona Boccardo, PhD, Jean Louis.
Phase I Trial of Cediranib in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Unresectable Malignant Pleural Mesothelioma (SWOG.
Elizabeth H. Baldini, MD, MPH, William G. Richards, PhD, Ritu R
Miliary Never-Smoking Adenocarcinoma of the Lung: Strong Association with Epidermal Growth Factor Receptor Exon 19 Deletion  Eckart Laack, MD, Ronald.
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
Complete Response Achieved 1 Year after a Single Administration of Nivolumab in a Patient with Lung Adenocarcinoma with Negative Expression of PD-L1 
An Unusual Presentation of Malignant Pleural Mesothelioma
Computed Tomography Findings Predicting Invasiveness of Thymoma
Supplementary Prognostic Variables for Pleural Mesothelioma: A Report from the IASLC Staging Committee  Harvey I. Pass, MD, Dorothy Giroux, MS, Catherine.
Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 
Coexistence of the BRAF Mutation and EGFR Exon 20 Insertion in a Patient with Lung Adenocarcinoma  Lih-Chyun Chang, MD, Kuan-Yu Chen, MD, PhD, Jin-Yuan.
The IASLC Lung Cancer Staging Project: Validation of the Proposals for Revision of the T, N, and M Descriptors and Consequent Stage Groupings in the Forthcoming.
Nikolaas De Maeyer, MD, Walter De Wever, MD, PhD, Christophe M
Esophageal Ultrasound-Controlled Fine Needle Aspiration for Staging of Mediastinal Lymph Nodes in Patients with Resectable Lung Cancer: Do We Always See.
Frequency of Use and Predictors of Cancer-Directed Surgery in the Management of Malignant Pleural Mesothelioma in a Community-Based (Surveillance, Epidemiology,
Patients’ Knowledge, Beliefs, and Distress Associated with Detection and Evaluation of Incidental Pulmonary Nodules for Cancer: Results from a Multicenter.
Vertebral Collapse Caused by Bone Metastasis
Kiran Devisetty, MD, Joseph K. Salama, MD  Journal of Thoracic Oncology 
A Practical Guide of the Southwest Oncology Group to Measure Malignant Pleural Mesothelioma Tumors by RECIST and Modified RECIST Criteria  Anne S. Tsao,
Association between Congenital Lung Malformations and Lung Tumors in Children and Adults: A Systematic Review  Arianna Casagrande, MD, Federica Pederiva,
Disease Flare After Treatment Discontinuation in a Patient With EML4-ALK Lung Cancer and Acquired Resistance to Crizotinib  Oana Pop, MD, Augustin Pirvu,
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification.
Mecit Kantarci, MD, PhD, Fadime Fil, MD, Ummugulsum Bayraktutan, MD 
Massive Bronchogenic Cyst
A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma  Valerie W. Rusch, MD, Ritu Gill, MD, Alan Mitchell,
Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response 
North American Multicenter Volumetric CT Study for Clinical Staging of Malignant Pleural Mesothelioma: Feasibility and Logistics of Setting Up a Quantitative.
Appropriateness of Surgical Approach in Black Patients with Lung Cancer—15 Years Later, Little Has Changed  Emanuela Taioli, MD, PhD, Raja Flores, MD 
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients  Raja.
Observer Variability in Mesothelioma Tumor Thickness Measurements: Defining Minimally Measurable Lesions  Samuel G. Armato, PhD, Anna K. Nowak, MD, PhD,
Osimertinib for Epidermal Growth Factor Receptor Mutation–Positive Lung Adenocarcinoma That Transformed to T790M-Positive Squamous Cell Carcinoma  Naoyuki.
A Simple Solution for Complicated Pleural Effusions
Multiple Primary Cancers or Multiple Metastases, That Is the Question
Spontaneous Pneumothorax and Lung Carcinoma: Should One Consider Synchronous Malignant Pleural Mesothelioma?  Trevor A. Flood, MD, Harman S. Sekhon, MD,
Jennifer S. Temel, MD, William F. Pirl, MD, Christopher J
Does Lymph Node Metastasis Have a Negative Prognostic Impact in Patients with NSCLC and M1a Disease?  Chenyang Dai, MD, Yijiu Ren, MD, Dong Xie, MD, PhD,
Patterns of Local and Nodal Failure in Malignant Pleural Mesothelioma After Extrapleural Pneumonectomy and Photon-Electron Radiotherapy  Vishal Gupta,
The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: Implications for revision of the.
Frequency and Prognostic Significance of Preoperatively Detected Enlarged Regional Lymph Nodes in Patients with Pathological Stage I Non-small Cell Lung.
Lung Volume Measurements as a Surrogate Marker for Patient Response in Malignant Pleural Mesothelioma  Zacariah E. Labby, PhD, Samuel G. Armato, PhD,
T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)
Paraneoplastic Limbic Encephalitis Attributable to Thymoma
Assessment of Therapy Responses and Prediction of Survival in Malignant Pleural Mesothelioma Through Computer-Aided Volumetric Measurement on Computed.
Clinical and Pathological Staging Validation in the Eighth Edition of the TNM Classification for Lung Cancer: Correlation between Solid Size on Thin-Section.
Linda L. Garland, MD, Kari Chansky, MS, Antoinette J
Recurrent Primary Synovial Sarcoma of the Chest Wall
Metastatic Lung Cancer to the Pancreas
Follow-Up of Small (4 mm or Less) Incidentally Detected Nodules by Computed Tomography in Oncology Patients: A Retrospective Review  Reginald F. Munden,
Positron emission tomography predicts survival in malignant pleural mesothelioma  Raja M. Flores, MD, Timothy Akhurst, MD, Mithat Gonen, PhD, Maureen Zakowski,
Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural.
Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non–Small Cell Lung Cancer 
Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database  Valerie W. Rusch, MD, Dorothy Giroux, Catherine.
Jamie E. Chaft, MD, Camelia S. Sima, MD, MS, Michelle S
Farhood Farjah, MD, MPH, David R. Flum, MD, MPH, Scott D
Rogerio C. Lilenbaum, MD, John Cashy, PhD, Thomas A
Stereotactic Body Radiotherapy for Central Lung Tumors
Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the.
Population-Based Patterns of Surgical Care for Stage IIIA NSCLC in the Netherlands between 2010 and 2013  Chris Dickhoff, MD, Max Dahele, MBChB., PhD,
Robert Comis, MD, The Passing of a “Lung Man”
Journal of Thoracic Oncology
Presentation transcript:

North American Multicenter Volumetric CT Study for Clinical Staging of Malignant Pleural Mesothelioma: Feasibility and Logistics of Setting Up a Quantitative Imaging Study  Ritu R. Gill, MD, MPH, David P. Naidich, MD, Alan Mitchell, MS, Michelle Ginsberg, MD, Jeremy Erasmus, MD, Samuel G. Armato, PhD, Christopher Straus, MD, Sharyn Katz, MD, PhD, Demetrois Patios, MD, BA, William G. Richards, PhD, Valerie W. Rusch, MD Valerie Rusch, MD, Michelle Ginsberg, MD, David Rice, MD, Jeremy Erasmus, MD, Harvey Pass, MD, David Naidich, MD, Hedy L. Kindler, MD, Samuel Armato, PhD, Christopher Straus, MD, Wickii Vigneshwaran, MD, Joseph Friedberg, MD, Sharyn Katz, MD, PhD, Marc de Perrot, MD, Demetrios Patios, MD, BA, Dori Giroux, MS, Dr. Lynn Shemanski, PhD, Alan Mitchell, MS, William G. Richards, PhD, Ritu R. Gill, MD, MPH Ritu R. Gill, MD, MPH, David P. Naidich, MD, Alan Mitchell, MS, Michelle Ginsberg, MD, Jeremy Erasmus, MD, Samuel G. Armato, PhD, Christopher Straus, MD, Sharyn Katz, MD, PhD, Demetrois Patios, MD, BA, William G. Richards, PhD, Valerie W. Rusch, MD Valerie Rusch, MD, Michelle Ginsberg, MD, David Rice, MD, Jeremy Erasmus, MD, Harvey Pass, MD, David Naidich, MD, Hedy L. Kindler, MD, Samuel Armato, PhD, Christopher Straus, MD, Wickii Vigneshwaran, MD, Joseph Friedberg, MD, Sharyn Katz, MD, PhD, Marc de Perrot, MD, Demetrios Patios, MD, BA, Dori Giroux, MS, Dr. Lynn Shemanski, PhD, Alan Mitchell, MS, William G. Richards, PhD, Ritu R. Gill, MD, MPH  Journal of Thoracic Oncology  Volume 11, Issue 8, Pages 1335-1344 (August 2016) DOI: 10.1016/j.jtho.2016.04.027 Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Flowchart showing the organizational setup of the study. CT, computed tomography; IASLC/IMIG, International Association for the Study of Lung Cancer/International Mesothelioma Interest Group; MPM, malignant pleural mesothelioma; DICOM, Digital Imaging and Communications in Medicine; TNM, tumor, node, and metastasis. Journal of Thoracic Oncology 2016 11, 1335-1344DOI: (10.1016/j.jtho.2016.04.027) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

Figure 2 Correlation of volumetric computed tomography (VolCT) analysis estimates of reader A compared with those of reader B. Journal of Thoracic Oncology 2016 11, 1335-1344DOI: (10.1016/j.jtho.2016.04.027) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

Figure 3 Comparison of tumor volume from both reference radiologists with pathological tumor (T) category. VolCT, volumetric computed tomography. Journal of Thoracic Oncology 2016 11, 1335-1344DOI: (10.1016/j.jtho.2016.04.027) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

Figure 4 Example of perception error. Axial computed tomography images with contrast from a patient with malignant pleural mesothelioma with a large right pleural effusion and discontinuous areas of pleural thickening representing tumor. Areas perceived as tumor by the two reviewers are represented by yellow (A) and red (B) contour lines, respectively, and the resulting difference in calculated tumor volume is as depicted in the three-dimensional volume-rendered images (C). Journal of Thoracic Oncology 2016 11, 1335-1344DOI: (10.1016/j.jtho.2016.04.027) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

Figure 4 Example of perception error. Axial computed tomography images with contrast from a patient with malignant pleural mesothelioma with a large right pleural effusion and discontinuous areas of pleural thickening representing tumor. Areas perceived as tumor by the two reviewers are represented by yellow (A) and red (B) contour lines, respectively, and the resulting difference in calculated tumor volume is as depicted in the three-dimensional volume-rendered images (C). Journal of Thoracic Oncology 2016 11, 1335-1344DOI: (10.1016/j.jtho.2016.04.027) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

Figure 5 Example of limited distinction between tumor and adjacent structures. (A and D) Depiction of corresponding sets of axial computed tomography images obtained without intravenous contrast in a patient with right-sided malignant pleural mesothelioma with similar density and therefore poor contrast among tumor, chest wall musculature, liver, and the mediastinal vascular structures (white arrows) demonstrating discrepant tumor delineation by the two reference radiologists, respectively. The resulting difference in calculated tumor volume is apparent by comparing the respective three-dimensional volume-rendered images (B and C). Journal of Thoracic Oncology 2016 11, 1335-1344DOI: (10.1016/j.jtho.2016.04.027) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions